Detection of Testosterone Microdosing in Wome
- Conditions
- Doping in sports.Metabolic and Endocrine - Normal metabolism and endocrine development and function
- Registration Number
- ACTRN12619000633189
- Lead Sponsor
- Sydney Local Health District
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 12
•Healthy women aged between 18 and 60 years
•Provide written, informed consent and willing to comply with all study requirements
•Pregnancy, breast feeding or seeking fertility within next 6 months
•Using hormonal drugs other than oral contraception (eg estrogen replacement)
•Athletes subject to regular urine drug testing
•Contraindication to testosterone (breast cancer, polycythemia)
•Major, serious or chronic medical disorders including chronic viral (HIV, hepatitis) infection that require regular prescribed medication
•Severe or extensive skin disease that interferes with transdermal drug delivery
•Regular medications that interfere with dermal absorption or metabolism of testosterone
•History of androgen or other drug abuse within last year
•History of major psychiatric disease or psychological condition that may limit understanding and compliance with study requirements in the investigator’s opinion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method